Skip to content
Menu

Truist Securities Maintains Hold on Teladoc Health, Raises Price Target to $9

Benzinga Newsdesk 9 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $9.

Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $9.

Read at benzinga.com